Johnson & Johnson COVID-19 Vaccine
Product
An adenovirus DNA vector vaccine, initially showing greater absolute risk reduction, later deemed less preferential by the CDC due to thrombosis risk and efficacy as a single dose.
Mentioned in 1 video
An adenovirus DNA vector vaccine, initially showing greater absolute risk reduction, later deemed less preferential by the CDC due to thrombosis risk and efficacy as a single dose.
